By Deena Beasley (Reuters) -Powerful weight-loss drugs are expanding use of U.S. health care as patients starting ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...

Moon So-young, an academic director at the Korean Dementia Society and a professor at Ajou University Hospital, noted, "If ...

Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...

By Anna Ringstrom and Maggie Fick STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ...

Landmark publication in leading ophthalmology research journal demonstrates the power of 4DMT’s Therapeutic Vector Evolution platform to invent ...

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...

Celltrion today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions and recommended marketing authorisations ...

Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing ...